Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
Murad Alahdal, Eyad Elkord
Clinical Immunology (2022) Vol. 245, pp. 109177-109177
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
Manish Dhawan, Ali A. Rabaan, Sara Alwarthan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 699-699
Open Access | Times Cited: 39
The Immunopathogenesis of a Cytokine Storm: The Key Mechanisms Underlying Severe COVID-19
Luka Hiti, Tijana Markovič, Mitja Lainščak, et al.
Cytokine & Growth Factor Reviews (2025)
Open Access | Times Cited: 3
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Longitudinal Follow‐Up of the Specific Antibody Response to SARS‐CoV‐2 Vaccination in Colombia
Myriam Arévalo‐Herrera, Bladimiro Rincón‐Orozco, John Mario González‐Escobar, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections
Ankita Saha, Anirban Ganguly, Anoop Kumar, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 129-129
Open Access
The causal effect of natural killer cells on COVID-19 infection, hospitalization and severity
Kaili Yang, Jun Quan, Zhi Long Liu, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm—A Powerful Therapeutic Tool for COVID-19 Patients
Mária Csöbönyeiová, Veronika Smolinská, Stefan Harsanyi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1736-1736
Open Access | Times Cited: 10
A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality
Thilo Gambichler, Jonas Rüth, Silke Goesmann, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 810-810
Open Access | Times Cited: 2
Adaptive immune dysfunction in patients with COVID-19 and impaired kidney function during the omicron surge
Jiayi Yan, Jieying Wang, Ding Li, et al.
Clinical Immunology (2023) Vol. 248, pp. 109271-109271
Open Access | Times Cited: 5
COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey
Mehmet Soylu, Pınar Sağıroğlu, Muhammed Alper Özarslan, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 59-59
Open Access | Times Cited: 1
Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review
Poramate Pitak‐Arnnop, Popchai Ngamskulrungroj, Nithi Mahanonda, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 385-385
Open Access | Times Cited: 1
Safety and Feasibility of Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19
Dolores Grosso, John L. Wagner, Allyson O’Connor, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 4113-4124
Open Access | Times Cited: 1
Tumor Antigen-Tethered Spiked Virus-Like- Poly(Lactic-Co-Glycolic Acid)-Nanoparticle Vaccine Enhances Antitumor Ability Through Th9 Promotion in Mice
Ting-Wei Lin, Po-Yu Chou, Yen-Ting Shen, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10983-11002
Open Access | Times Cited: 1
Alterations in the CD56− and CD56+ T Cell Subsets during COVID-19
Julia D. Vavilova, Maria O. Ustiuzhanina, Anna A. Boyko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9047-9047
Open Access | Times Cited: 3
Characterizing distinct profiles of immune and inflammatory response with age to Omicron infection
Lina Zhang, Zhanwen Wang, Feng Lyu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Study of CD4+ T-lymphocytes in chronic kidney disease patients with COVID-19 infection
Tamer Mohamed
Egyptian journal of Immunology (2024) Vol. 31, Iss. 01, pp. 155-161
Open Access
Enhanced Immunomodulatory Effects of Thymosin-Alpha-1 in Combination with Polyanionic Carbosilane Dendrimers against HCMV Infection
María de la Sierra Espinar-Buitrago, Esmeralda Magro-López, Elena Vázquez‐Alejo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1952-1952
Open Access
K33 only mutant ubiquitin augments bone marrow‐derived dendritic cell‐mediated CTL priming via PI3K‐Akt pathway
Yi Liang, Xiao Yan Liao, Jun Jun Jia, et al.
Immunology (2024) Vol. 172, Iss. 3, pp. 486-499
Closed Access
Comparison of Acute COVID-19 Encephalopathy with Seasonal Influenza A-associated Encephalopathy
Jialu Xu, Wei Li, Yilin Zhu, et al.
Iranian Journal of Pediatrics (2024) Vol. 34, Iss. 3
Open Access
Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling
Evelyn Zarate-Sanchez, Steven C. George, Monica L. Moya, et al.
Biofabrication (2024) Vol. 16, Iss. 3, pp. 032008-032008
Open Access
A Negative Regulatory Feedback Loop within the JAK–STAT Pathway Mediated by the Protein Tyrosine Phosphatase DUSP14 in Shrimp
M. Luo, Nuo Chen, Deyu Han, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 1, pp. 63-74
Closed Access
mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells
Siqi Liu, Laura L.A. van Dijk, Yvette den Hartog, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126250-126250
Closed Access
The Effects of Severe Symptoms of SARS-CoV-2 Infections on the Anti/Proapoptotic Molecules: A 6-Month Cohort Study
Masoud Karimi‐Googheri, Zahra Madjd, Jafar Kiani, et al.
Viral Immunology (2024)
Closed Access
T-Cell Phenotypes and Systemic Cytokine Profiles of People Living with HIV Admitted to Hospital with COVID-19
Mieke A. van der Mescht, Helen C. Steel, Zelda de Beer, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2149-2149
Open Access
Immunosuppressants in dermatology on vaccine immunogenicity: a prospective cohort study of pemphigus patients in the pandemic
Kun‐Lin Lu, Hua-En Lee, Chun‐Bing Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top